📊 $2 billion+ medical device market | 215 million population | 75%+ of medical devices imported | Largest healthcare market in Latin America
Brazil is the largest healthcare market in Latin America and among the most significant medical device import markets in the world. With a population of 215 million, a public healthcare system (SUS — Sistema Unico de Saude) managing the world’s largest single-payer health network, and a private sector with over 4,500 private hospitals, Brazil’s surgical instrument procurement operates at scale that few emerging markets can match.
Brazil’s Hospital Procurement Structure
Public hospital procurement in Brazil operates through Compras.gov.br (formerly ComprasNet) — the federal government’s e-procurement portal. States manage their own public hospital purchasing, often running separate tender processes. Private hospital groups — including Rede D’Or Sao Luiz (Latin America’s largest hospital group), Hapvida Nordeste, and Notre Dame Intermédica — run sophisticated procurement operations that evaluate international certified suppliers directly.
Key instrument categories in consistent demand include general surgery sets, obstetric and gynecology instruments (Brazil has one of the world’s highest cesarean section rates at over 55%), laparoscopic instrument sets (MIS adoption is high in private sector hospitals), bone surgery tools, and CSSD holloware at all hospital levels.
ANVISA Registration Requirements
Brazil’s Agencia Nacional de Vigilancia Sanitaria (ANVISA) regulates all medical devices under RDC 751/2022, which came into force on 1 March 2023 and revoked the long-standing RDC 185/2001. The new resolution adopts the 22 risk-classification rules of the EU MDR in place of the older 18-rule scheme, which means a CE classification dossier now maps onto the Brazilian one far more directly than it used to. Surgical instruments are classified as Class I (lowest risk), and registration requires manufacturer ISO 13485 certification as the primary quality document. ANVISA registration is processed by a licensed Brazilian importer acting as the Authorized Representative. We work with established Brazilian importers who hold ANVISA registration for our product categories and can manage the complete regulatory pathway.
- ISO 13485:2016 certified — ANVISA mandatory requirement
- CE marking under MDR 2017/745 — internationally recognized
- AISI 410/420 martensitic steel for instruments, 304/316L for holloware – specified per product, not blanket-claimed
- Competitive pricing versus European and US brands
- Full technical documentation for ANVISA submission
Cadastro or Registro: Which Route Your Instruments Take
The single most useful thing RDC 751/2022 did for an instrument exporter is separate the two regulatory regimes cleanly. Class I and Class II devices go through Cadastro — a notification route. Class III and Class IV go through Registro, a full registration with technical dossier review.
Reusable non-invasive surgical instruments almost always land in Class I. That places them in the notification lane, which is materially faster and cheaper than the route many exporters assume they face. The dossier still has to exist and still has to be right; it simply is not queued behind the same review backlog as an implantable device.
What does not change with class is the need for a Brazilian legal entity to hold the registration. ANVISA does not register a foreign manufacturer directly. Your importer, distributor or a dedicated Brazil Registration Holder files in their own name, and that has a commercial consequence worth understanding before you sign anything: whoever holds the registration controls market access. Transferring a holding to a second importer later is possible but slow.
| Item | Typical surgical instrument position | Who provides it |
|---|---|---|
| Risk class (RDC 751/2022, Annex I) | Class I — reusable, non-invasive | Determined jointly; mirrors EU MDR rule set |
| Regulatory regime | Cadastro (notification) | ANVISA |
| Quality system evidence | ISO 13485:2016 certificate | Manufacturer |
| Good Manufacturing Practice | Not normally required for Class I Cadastro | ANVISA (audit for higher classes) |
| Free sale evidence | Certificate of Free Sale or CE certificate | Manufacturer / notified body |
| Portuguese labelling and IFU | Mandatory, Brazilian Portuguese | Manufacturer, importer reviews |
| Registration holder | Brazilian legal entity with AFE licence | Importer / distributor |
Two documents cause more delay than anything else. The first is the Certificate of Free Sale, which has to be legalised for Brazil and frequently arrives with the wrong scope or an expired date. The second is the Portuguese instructions for use: a machine translation will be rejected, and the reprocessing instructions in particular have to match what the manufacturer actually validated.
Shipping and Payment Notes for Brazil
Brazil applies substantial import duty and state-level ICMS tax to medical devices, and the landed cost is meaningfully higher than the invoice value. Quote EXW or FOB and let the importer model their own landed cost — a DDP quote into Brazil without a specialist broker is a good way to lose money on tax you did not anticipate.
Nearly all first orders from Brazilian buyers come as air freight into Guarulhos (GRU) or Viracopos (VCP). Sea freight to Santos becomes worthwhile at roughly a pallet and above. Payment terms are typically T/T in advance for a first order, moving to a letter of credit or 30–60 day terms once a relationship is established. Our guide to Incoterms for instrument exports covers where the risk transfers on each of these.
Frequently Asked Questions
Do surgical instruments need full ANVISA registration or just notification?
Class I reusable surgical instruments go through Cadastro — notification — rather than the full Registro pathway reserved for Class III and IV devices. It is faster and less costly, but the underlying technical documentation still has to be complete and accurate.
Can a foreign manufacturer hold the ANVISA registration directly?
No. A Brazilian legal entity holding a valid AFE (Autorizacao de Funcionamento de Empresa) must hold it. That is normally your importer or distributor, though dedicated Brazil Registration Holder services exist if you want the holding kept independent of any one commercial partner.
How long does the process take for Class I instruments?
Timelines move with ANVISA’s workload, so treat any figure as indicative. The notification route for Class I is measured in months rather than the year-plus that higher-class registrations can take. The realistic bottleneck is usually document preparation and legalisation on the exporter’s side, not ANVISA’s queue.
Is a CE certificate enough on its own?
It is not a substitute for ANVISA notification, but it helps considerably. Since RDC 751/2022 adopted the EU MDR classification rules, the classification logic behind a CE dossier now maps closely onto the Brazilian one, and CE evidence supports the free-sale documentation. You still file in Brazil.
Does labelling have to be in Portuguese?
Yes, in Brazilian Portuguese, and this is not a place to economise. Labels and instructions for use must carry the ANVISA number, the registration holder’s details, and reprocessing instructions consistent with the manufacturer’s validation. Rejected labelling is one of the most common and most avoidable causes of a delayed first shipment.
2026 update: the regulatory references on this page were revised to reflect RDC 751/2022, which replaced RDC 185/2001 with effect from 1 March 2023 and aligned Brazilian risk classification with the EU MDR rule set.
Contact Fizza Surgical for pricing, catalog, or to connect with our ANVISA-registered Brazilian import partners. DHL Express to Sao Paulo and Rio in 5–7 business days.
Where We Serve
Fizza Surgical exports to 50+ countries. Browse our country-specific pages with local regulatory guidance and pricing:
